Seth Seegobin

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

Javier Cortés, Joyce O’Shaughnessy, David Loesch et al. · The Lancet · 2011 · 1.1K citations

Medicine, Oncology, Pharmacotherapy +9

Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial

Ruth Cooper, Emma Williams, Seth Seegobin et al. · European Neuropsychopharmacology · 2017 · 170 citations

Medicine, Neuroscience, Pharmacology +9

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

Sophie Glatt, Gregor B. E. Jemec, Seth Forman et al. · JAMA Dermatology · 2021 · 167 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +16

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02

Christos Tziotzios, Christos Petridis, Nick Dand et al. · Nature Communications · 2019 · 120 citations · Full text

Life Sciences, Dermatology, Genetics +17

ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

Seth Seegobin, Margaret HY, Chanaka Dahanayake et al. · Arthritis Research & Therapy · 2014 · 104 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15